Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice-Reference-Cited by-同舟云学术

Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

Published:2015-03-31 Issue:4 Volume:9 Page:3540-3557
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Meng Huan,Wang Meiying,Liu Huiyu¹,Liu Xiangsheng,Situ Allen,Wu Bobby,Ji Zhaoxia,Chang Chong Hyun,Nel Andre E.

Affiliation:

1. Laboratory of Controllable Preparation and Application of Nanomaterials, Research Center for Micro & Nano Materials and Technology, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, People’s Republic of China

Funder

National Natural Science Foundation of China

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.5b00510

Reference63 articles.

1. Cancer Facts & Figures; American Cancer Society, 2014; http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf.

2. Cellular pharmacology of gemcitabine